Home > Current issue

UIJ - Ureteroscopic Lithotripsy Under Local Anesthesia and Without Intravenous Analgesia in Adults: Analysis of the Effectiveness and Patient Tolerability of About 100 Patients

Satâa Sallami1, Adel Dahmani1, Gammoudi Anis1, Ali Horchani1

1 Department of Urology, La Rabta University Hospital. Tunis TUN.

Date Received July 16, 2011
Accepted on September 02, 2011
Original Publication Date November 21, 2011
E-mail

ABSTRACT

Objective: We evaluated the feasibility and effectiveness of ureteroscopic lithotripsy for ureteral stones under local anesthesia without any sedation.

Methods: Prospectively, ureteroscopic lithotripsy under local anesthesia was performed in 100 patients (45 males and 55 females). A rigid endoscope (8.5 to 11.5 Fr) was used in all cases. Local anesthesia consists of lidocaine jelly in the bladder associated with a penile nerve block in males only, and without any intravenous analgesia. Ureteroscopy was done for stone fragmentation with a double-J catheter insertion in 13 patients. We compared the pain perception during ureteroscopy to that of cystoscopy performed during the same procedure, using a visual-analogue pain scale recorded by the patient.

Results: The overall success rate was 82%. The success rates of the upper, mid, and lower ureteral calculi were 71.4%, 72.7%, and 89%, respectively. The success rate was 100% in calculi less than 10 mm, and 80.3% in those more than 10 mm. Postoperatively, 1 patient developed pyelonephritis. We didn’t report any cases of ureteral perforation. The mean pain scale score was lower during the ureteroscopy (3.61 [2.2 to 8.5]) than in cystoscopy (4.52 [1.5 to 8] [p <0.001]). Almost all patients tolerated pain well during the procedure. The procedure was interrupted in only 5 patients and was performed later under spinal anesthesia. Postoperative pain was also tolerable in most patients, and only 8 patients required additional analgesics after the procedure.

Conclusion: Our findings suggest that most of the patients could tolerate the pain during a rigid ureteroscopic lithotripsy under local anesthesia. This procedure does not increase the risk of complications or compromises the results of treatment. Thus, it may be recommended in carefully selected and informed patients and performed with experienced hands.

KEYWORDS: Ureteroscopy; Local anesthesia; Stone; Lithotripsy; Pain

CORRESPONDENCE: Satâa Sallami, Department of Urology, La Rabta Hospital, University of Tunis, El Manar, Tunis, Tunisia (sataa_sallami@yahoo.fr).

CITATION: UroToday Int J. 2011 Dec;4(6):art 77. http://dx.doi.org/10.3834/uij.1944-5784.2011.12.10

Login to view this Article.Login Here

case diagnosis


Presented by the Warren Alpert Medical School of Brown University, Office of Continuing Medical Education.

Target Audience

This activity is designed for urologists and other healthcare professionals interested in or involved with the management of bladder cancer.

Educational Objectives

Upon completion of this activity, participants should be able to:

  1. Discuss the epidemiology of bladder cancer including prevalence, mortality, and risk factors
  2. Describe the economic impact of bladder cancer and how improved techniques for initial detection and at the time of transurethral resection of bladder tumor (TURBT) may decrease the economic burden
  3. Compare and contrast new urine biomarkers when compared to urine cytology
  4. Discuss the role of photodynamic diagnosis using hexaminolevulinate-guided fluorescence cystoscopy in detecting carcinoma in situ and residual disease at the time of TURBT compared to traditional white-light cystoscopy (WLC)
  5. Optimize use of intravesical therapy after TURBT to prevent recurrence of bladder...

An Expert Panel Interview

Educational Objectives

At the conclusion of this activity, participants should be able to:

  • Identify patients with castrate-resistant prostate cancer (CRPC)

  • Review current and future modalities available for the treatment of CRPC.

  • Discuss therapeutic strategies that may mitigate skeletal adverse events associated with metastatic prostate cancer and its treatment.

  • Program Release: April 1, 2011

  • Program Expiration: April 30, 2012

  • Estimated time to complete: 60 minutes

  • There are no prerequisites for participation.

  • 1 AMA PRA Category 1 Credit™

  • Educational grant provided by Amgen Inc and Dendreon Corporation.

mobile news
Visit our mobile news channel today and get the latest Urological reviews, conference coverage, surgical techniques, clinical updates and more!